The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics

by Rob Lambkin-Williams, Nicolas Noulin, Alex Mann, Andrew Catchpole, Anthony S. Gilbert
Published 2018-06-01

The manufacturing of human viral challenge agents for use in clinical studies to accelerate the drug development process

by Andrew P. Catchpole, Daniel J. Fullen, Nicolas Noulin, Alex Mann, Anthony S. Gilbert, Rob Lambkin-Williams
Published 2018-08-01

Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model...

by Daniel J Fullen, Nicolas Noulin, Andrew Catchpole, Hosnieh Fathi, Edward J Murray, Alex Mann, Kingsley Eze, Ganesh Balaratnam, Daryl W Borley, Anthony Gilbert, Rob Lambkin-Williams
Published 2016-01-01

Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Cha...

by Daniel J Fullen, Nicolas Noulin, Andrew Catchpole, Hosnieh Fathi, Edward J Murray, Alex Mann, Kingsley Eze, Ganesh Balaratnam, Daryl W Borley, Anthony Gilbert, Rob Lambkin-Williams
Published 2016-01-01

Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge.

by Alex J Mann, Nicolas Noulin, Andrew Catchpole, Koert J Stittelaar, Leon de Waal, Edwin J B Veldhuis Kroeze, Michael Hinchcliffe, Alan Smith, Emanuele Montomoli, Simona Piccirella, Albert D M E Osterhaus, Alastair Knight, John S Oxford, Giulia Lapini, Rebecca Cox, Rob Lambkin-Williams
Published 2014-01-01